Are you currently taking Vyndamax or considering it as a treatment option?
Vyndamax (tafamidis) is an FDA-approved medication for treating wild-type and hereditary ATTR amyloidosis with cardiomyopathy. It works as a TTR stabilizer, helping the transthyretin protein maintain its correct shape to prevent misfolding and Show Full Answer
Are you currently taking Vyndamax or considering it as a treatment option?
Vyndamax (tafamidis) is an FDA-approved medication for treating wild-type and hereditary ATTR amyloidosis with cardiomyopathy. It works as a TTR stabilizer, helping the transthyretin protein maintain its correct shape to prevent misfolding and reduce amyloid buildup in the heart.
Some people on MyAmyloidosisTeam have shared their experiences with Vyndamax and similar medications. It's worth connecting with others who may be taking it to learn about their experiences. Regarding amyloid-clearing drugs, researchers are actively studying medications that could remove existing amyloid deposits. One medication called PRX004 is currently being studied for its potential to treat hereditary or wild-type ATTR amyloidosis.
Recently approved medications include:
* Acoramidis (Attruby) - approved in 2024 for ATTR-CM
* Vutrisiran (Amvuttra) - approved in March 2025 for ATTR-CM
These newer treatments focus on preventing amyloid formation rather than clearing existing deposits. Clinical trials are ongoing, so it's worth discussing with your doctor whether any upcoming trials might be appropriate for you.
January 23
Join
Your Privacy Choices
